Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall.
Chipps BE, Murphy KR, Wise RA, McCann WA, Beuther DA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Ross M, Zeiger RS.
Chipps BE, et al. Among authors: zeiger rs.
Ann Allergy Asthma Immunol. 2022 May;128(5):544-552.e3. doi: 10.1016/j.anai.2022.01.035. Epub 2022 Feb 3.
Ann Allergy Asthma Immunol. 2022.
PMID: 35123077